New Incisionless Heartburn Surgery Option Now Available for the Nearly 14 Million Americans Suffering From Daily Acid Relux
Glendale Adventist Medical Center performs the first Transoral Incisionless Fundoplication (TIF) for the treatment of gastroesophageal reflux
GLENDALE, CA – July 7, 2011 – For Jaime Corral, 43, of Los Angeles, his recent Transoral Incisionless Fundoplication (TIF) surgery at Glendale Adventist Medical Center was life-changing.
“Before, I could not have a good day if I didn’t take anti-reflux medication. Even on the medication I still had to be careful about my diet. I couldn’t drink coffee or eat a lot of my favorite foods. The surgery has completely changed my lifestyle. I’m able to sleep better, I don’t have to take the medications, I can eat foods I couldn’t eat before, and I’m not always worried about whether what I’m eating is going to give me heartburn. I even had a cup of coffee three days after the surgery without a problem.”
By definition, surgery has always meant cutting into the body. Not at Glendale Adventist Medical Center. Sam Carvajal, MD, surgeon recently performed the first incisionless surgery at Glendale Adventist Medical Center for the treatment of gastroesophageal reflux disease (GERD).
Transoral Incisionless Fundoplication or “TIF” using the EsophyX device is the latest treatment for safely and effectively treating chronic GERD, a severe form of heartburn that occurs when the valve between the stomach and esophagus becomes defective and allows stomach fluid to back up into the esophagus. Medications can relieve symptoms but don’t solve the underlying anatomical problems or keep the disease from progressing. Left untreated, GERD has been associated with esophageal ulcers, bleeding and scarring of the esophagus and an increased risk of cancer of the esophagus. Additionally, current studies indicate that prolonged use of over-the-counter reflux medications can cause increased risk of bone fractures.
Dr. Carvajal, a leader in the treatment of GERD, explains how TIF works. “The patient is put under general anesthesia, and the EsophyX device is advanced into the esophagus through the mouth. A video camera inserted in the central shaft of the device lets us see our progress. We then use the EsophyX device to create a one-way valve from tissue folds at the gastroesophageal junction. The valve blocks stomach acid from refluxing into the esophagus. ”
Because it completely avoids any incisions, the procedure results in a shorter hospital stay (usually just overnight), reduced patient discomfort, shortened recovery times, no visible scars, and typically higher patient satisfaction than other types of surgery to treat GERD.
Estimates show that approximately 14 million Americans suffer the daily symptoms of acid reflux.
For those millions of Americans diagnosed with GERD and not fully satisfied with their treatment options, TIF with the EsophyX device offers an excellent alternative, says Dr. Carvajal. “Before surgery many reflux patients can’t drink soda or coffee or eat rich foods or fruit without triggering reflux. Many sleep sitting up. Studies show that 70 percent of patients remain symptom-free two years after TIF surgery. They’re back to living life on their own terms.”
For more information about Glendale Adventist Medical Center, call (818) 409-8100 or visit the website.